Outcomes of COVID-19 in Recent Kidney Transplants Recipients at a Large Transplant Center in Miami
Open Forum Infectious Diseases
; 8(SUPPL 1):S756, 2021.
Article
in English
| EMBASE | ID: covidwho-1746297
ABSTRACT
Background. Outcomes of COVID-19 have been reported in deceased donor kidney transplant (DDKT) recipients. However, data is limited in patients that underwent recent DDKT. Methods. This single-center retrospective study evaluated the differences in demographics and post-transplant outcomes between those who tested positive and negative for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by polymerase chain reaction, after undergoing recent DDKT. The treatments and outcomes for the SARS-CoV-2-positive patients were assessed. Patients who underwent DDKT from 3/2020 to 8/2020 were included and followed until 9/2020. Results. 201 DDKT recipients were analyzed [14(7%) SARS-CoV-2-positive and 187(93%) negative]. There was no difference in delayed graft function and biopsy-proven rejection between both groups. The patient survival at the end of the study follow-up was lower among SARS-CoV-2-positive patients (Table 1). The median time from DDKT to COVID-19 diagnosis was 45 (range 8-90) days;5(36%) patients required intensive care unit and 4(29%) required mechanical ventilation;steroids were used in all the patients, therapeutic plasma exchange (TPE) and convalescent plasma (CP) in 7(50%) patients each, remdesivir in 6(43%) and tocilizumab in 1(7%);9(64%) patients recovered, 3(21%) died and two were still requiring mechanical ventilation at the end of the follow-up. Conclusion. Our cohort demonstrated a lower survival rate among SARSCoV-2-positive patients, which highlights the vulnerability of the transplant population. Transplant patients must comply with the CDC recommendations to prevent COVID-19.
convalescent plasma; remdesivir; steroid; tocilizumab; adult; artificial ventilation; clinical assessment; cohort analysis; conference abstract; controlled study; coronavirus disease 2019; deceased donor; delayed graft function; demographics; drug therapy; female; follow up; gene amplification; human; intensive care unit; kidney graft; major clinical study; male; nonhuman; outcome assessment; overall survival; plasma exchange; polymerase chain reaction; prevention; retrospective study; Severe acute respiratory syndrome coronavirus 2; surgery; survival rate; vulnerability
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Open Forum Infectious Diseases
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS